Clinical Trial of Efficacy and Safety of Prospecta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:August 19, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:August 19, 2022Completed
Condition(s):Menopause; Sleep DisorderLast Updated:January 2, 2024Not yet recruiting
Condition(s):Erector Spinae Plane Block; Lumbar Spine SurgeryLast Updated:July 23, 2021Unknown status
Condition(s):Chronic Abacterial Prostatitis; Chronic Pelvic Pain SyndromeLast Updated:March 21, 2013Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:April 26, 2017Terminated
Condition(s):Attention-deficit Hyperactivity DisorderLast Updated:June 9, 2015Completed
Condition(s):Pitt Hopkins SyndromeLast Updated:March 20, 2024Recruiting
Condition(s):Behcet’s Disease; VasculitisLast Updated:July 3, 2023Completed
Condition(s):Neuropathic PainLast Updated:March 1, 2024Recruiting
Condition(s):Urinary Bladder, Overactive; Sexual Behavior; Sexual Activity; Behavior Therapy; Sexual Function DisturbancesLast Updated:October 5, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.